• DoD bill will fund biological attack sensors

    The $636 billion Defense bill will send money to Michigan for bioterror research; $1.6 million will go to Dexter Research Center in Dexter, Michigan, to continue its development of a security sensor meant to protect military installations from chemical and biological attacks; Kettering University in Flint, Michigan will receive $1.6 million to help DoD with its Chemical Agent Fate Program

  • Maine to receive more than $3 million to aid bioterror research

    Research institutions in Maine will receive more than $3 million for bioterrorism research; a grant of $1.9 million will go to Orono Spectral Solutions to continue its development of an infrared detection system for chemical and biological agents; another $1.3 million will be set aside for Sensor Research & Development in Orono, for real time test monitoring of chemical agents, chemical agent stimulants and toxic industrial chemicals

  • Regional biodefense stockpiles could aid Europe in event of bioattack

    A plan for European preparation for a terrorist bioattacks calls for a regional stockpiling system within Europe; a Baltic stockpile, Nordic stockpile, and so on would be of great import and would aid in covering countries that have not expressed a desire to form their own stockpiles.

  • Senator Cochran’s earmark savvy benefits Mississippi biodefense center

    Republican Senator Thad Cochran of Mississippi is famous for his support of federal earmarks and regularly ranks near the top among senators for the number and size of his annual earmark haul; on Sunday the Senate passed a $1.1 trillion omnibus federal spending bill for the 2010 fiscal year, and Cochran managed to insert $150 million worth of earmarks for Mississippi; among the beneficiaries is Jackson State University’s National Center for Biodefense Communications, which conducts research and compiles data on bioterrorism threats to agriculture, and which is slated to receive $750,000 through the bill

    • view counter

  • Expert: U.S. stance on bioweapons important, does not require inspectors

    The Obama administration has been criticized for, on the one hand, expressing more support than its predecessor for the goals of the Biological Weapons Convention but, on the other hand, for continuing the Bush administration’s objection to a tight inspection regime; an expert says inspections are appropriate for nuclear weapons, but largely irrelevant to biological weapons

  • Combating bioterrorism needs to be a collaborative effort

    ISBI founder: “If you want to damage the United States, from a terrorist perspective, there are ways to do this extremely effectively that do not entail an attack on the U.S. homeland. There are ways that our economy could be catastrophically devastated and our political system substantially set back in terms of our global leadership that have nothing to do with a centralized domestic attack. Our vulnerabilities do not stop at the border’s edge.”

    • view counter

  • OSU president Burns Hargis defends anthrax research cancellation decision

    Hargis had ended an anthrax vaccine research project at OSU because it would have resulted in euthanizing baboons; he says he did not bow to pressures from animal rights activists – or from the wife of billionaire T. Boone Pickens, both OSU alumni and major donors to the school.

  • Military researcher infected with tularemia at research laboratory

    Researchers at U.S. Army Research Institute of Infectious Diseases has contracted tularemia; tularemia, which is not transmitted by person to person contact, is considered a potential agent of bioterrorism and biowarfare.

  • Bio espionage: New threat to U.S. economy

    In January, DHS warned of an increased cyber attack threat by activists/hacktivists and extremist groups; these groups are known to target life sciences and biotech companies; life sciences sector, pharmaceutical sector, and biotech sector are areas where we should expect information security challenges to increase exponentially for the foreseeable future

  • U.S. DNA suppliers warned against bioterrorism threat

    Analysts have expressed concern that DNA sequences can be abused to terrorize and harm entire populations without so much as a bang; the Department of Health and Human Services issued guidelines for the trade in customized DNA sequencing that, if abused, can lead to bioterrorism, with unforeseeable consequences.

  • New guidelines for genetic screening to prevent bioterrorism split scientists

    As the production of very accurate and valid scientific results from genetic screening has become more common among synthetic-biology companies, a fear that this ability will allow bioterrorists to exploit the system has arisen; there is a disagreement over the best method of genetic screening.

  • Bioattack threat to U.S. ignored

    The risk of a bioterror attack on the United States is huge; a one-to-two kilogram release of anthrax spores from a crop duster plane could kill more Americans than died in the Second World War (over 400,000), and the clean-up and other economic costs of such an attack could exceed $1.8 trillion; a former White House official says that U.S. media outlets do not cover this story, and it does not appear that the U.S. government is treating it the problem with the proper urgency

  • Potent new biodefense technology shows promise

    Medizone International’s AsepticSure technology continues to break the “6 log” decontamination barriers, this time with two very different spore forming bacteria, Claustridium difficile and Bacillis subtilis

  • Oklahoma State rejects anthrax study over euthanasia of primates

    The U.S. National Institutes of Health wanted OSU to conduct research on treatment for anthrax; the study involves baboons, which must be destroyed after anthrax exposure to ensure they do not infect others; In April, OSU announced that animals will no longer be euthanized in teaching labs at the veterinary school; measure was the result of pressure by Madeleine Pickens, the wife of billionaire benefactor and OSU alumnus T. Boone Pickens

  • Experts call for changes in U.S. vaccine creation process

    The current U.S. vaccine-manufacturing plan was developed prior to the cold war, and has never been updated; currently, the United States grows its vaccines in eggs over the course of six to eight months, and as there has been no real financial incentive to upgrade the vaccine making process, pharmaceutical manufacturers have instead focused on more profitable medications rather than vaccines